As of 2026-01-07, the Fair Value of Cytokinetics Inc (CYTK) is -30.75 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 64.60 USD, the upside of Cytokinetics Inc is -147.60%.
With the market price of 64.60 USD and our fair value calculation, Cytokinetics Inc (CYTK) is not a good investment. Investing in CYTK stocks now will result in a potential loss of 147.60%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -127.30 | -215.30 | -389.00 | -526.24 | -589.53 | -369.47 |
| YoY growth | -4.60% | -69.13% | -80.68% | -35.28% | -12.03% | -40.34% |
| Market Cap (mil) | 7,898.00 |
| P/E | |
| Forward P/E |
| EPS | -6.15 |
| Avg earnings growth rate | -40.34% |
| TTM earnings | -751.92 |